Revisiting Desensitization and Allergen Immunotherapy Concepts for the International Classification of Diseases (ICD)-11  Luciana Kase Tanno, MD, PhD, Moises A. Calderon, MD, PhD, Nikolaos G. Papadopoulos, MD, PhD, Mario Sanchez-Borges, MD, PhD, Lanny J. Rosenwasser, MD, PhD, Jean Bousquet, MD, PhD, Ruby Pawankar, MD, PhD, Juan Carlos Sisul, MD, PhD, Alfonso Mario Cepeda, MD, PhD, James Li, MD, PhD, Antonella Muraro, MD, PhD, Stanley Fineman, MD, MBA, James L. Sublett, MD, PhD, Constance H. Katelaris, MD, PhD, Yoon-Seok Chang, MD, PhD, Hee-Bom Moon, MD, PhD, Thomas Casale, MD, Pascal Demoly, MD, PhD  The Journal of Allergy and Clinical Immunology: In Practice  Volume 4, Issue 4, Pages 643-649 (July 2016) DOI: 10.1016/j.jaip.2015.12.022 Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Figure 1 Searching “desensitization” and “immunotherapy” in the ICD-11 β-draft foundation (August 2015 version). The Journal of Allergy and Clinical Immunology: In Practice 2016 4, 643-649DOI: (10.1016/j.jaip.2015.12.022) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions